CR Bard completes MedChem Products takeover:
This article was originally published in Clinica
CR Bard has completed the takeover of MedChem Products, announced in May (see Clinica No 657, p 11). MedChem shareholders will receive one Bard share per 3.25 MedChem shares. MedChem's Gesco line of vascular access catheters will become part of Bard Access Systems division, headquartered in Salt Lake City, Utah. MedChem Products will retain the haemostasis and wound closure products and operate as a new Bard division with headquarters in Woburn, Massachusetts.